A new study maps the organisation of immune and stromal cells in lymph nodes and shows how loss of this organisation affects ...
Initiated a formal process to monetize assets Implemented a restructuring plan to significantly reduce operating expenses and extend runwaySAN ...
SHANGHAI and NANJING, China and PLEASANTON, Calif., March 24, 2026 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company focused on the discovery, development, ...
Pharmaceutical Technology on MSN
Gilead acquires first TCE asset with $2.2bn Ouro Medicines buyout
This atypical deal structure will see Gilead collaborate with Galapagos to develop gamgertamig for the treatment of B-cell ...
Q4 2025 Earnings Call March 25, 2026 8:00 AM EDTCompany ParticipantsChris Chen - CEO & Executive DirectorMing Tu ...
Galapagos (NASDAQ:GLPG) said it has entered into a binding collaboration agreement with Gilead focused on Gamgertamig, a BCMA ...
SBio Inc. (01530.HK) today released its 2025 annual results announcement. Fueled by the dual core engines of breakthroughs in innovative R&D and strategic global collaboration, the company delivered a ...
Adagene (NASDAQ:ADAG) outlined its clinical and strategic priorities at Leerink Partners’ global healthcare conference, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results